178 related articles for article (PubMed ID: 32924090)
1. Expression of the immune checkpoint molecule V-set immunoglobulin domain-containing 4 is associated with poor prognosis in patients with advanced gastric cancer.
Kim SW; Roh J; Lee HS; Ryu MH; Park YS; Park CS
Gastric Cancer; 2021 Mar; 24(2):327-340. PubMed ID: 32924090
[TBL] [Abstract][Full Text] [Related]
2. Identification of a novel immune checkpoint molecule V-set immunoglobulin domain-containing 4 that leads to impaired immunity infiltration in pancreatic ductal adenocarcinoma.
Jiang Y; Han L; Yang J; Yang M; Zhang J; Xue M; Zhu Y; Xiong C; Shi M; Zhao S; Shen B; Xu Z; Jiang L; Chen H
Cancer Immunol Immunother; 2023 Aug; 72(8):2701-2716. PubMed ID: 37097516
[TBL] [Abstract][Full Text] [Related]
3. The immune checkpoint molecule V-set Ig domain-containing 4 is an independent prognostic factor for multiple myeloma.
Roh J; Jeon Y; Lee AN; Lee SM; Kim Y; Sung CO; Park CJ; Hong JY; Yoon DH; Suh C; Huh J; Choi I; Park CS
Oncotarget; 2017 Aug; 8(35):58122-58132. PubMed ID: 28938542
[TBL] [Abstract][Full Text] [Related]
4. The clinical implications of FDG-PET/CT differ according to histology in advanced gastric cancer.
Chon HJ; Kim C; Cho A; Kim YM; Jang SJ; Kim BO; Park CH; Hyung WJ; Ahn JB; Noh SH; Yun M; Rha SY
Gastric Cancer; 2019 Jan; 22(1):113-122. PubMed ID: 29948387
[TBL] [Abstract][Full Text] [Related]
5. PD-L1 Expression and CD8
Wang Y; Zhu C; Song W; Li J; Zhao G; Cao H
J Immunol Res; 2018; 2018():4180517. PubMed ID: 30003113
[TBL] [Abstract][Full Text] [Related]
6. Correlation between immune-related adverse events and prognosis in patients with gastric cancer treated with nivolumab.
Masuda K; Shoji H; Nagashima K; Yamamoto S; Ishikawa M; Imazeki H; Aoki M; Miyamoto T; Hirano H; Honma Y; Iwasa S; Okita N; Takashima A; Kato K; Boku N
BMC Cancer; 2019 Oct; 19(1):974. PubMed ID: 31638948
[TBL] [Abstract][Full Text] [Related]
7. The Significance of VSIG4 Expression in Ovarian Cancer.
Byun JM; Jeong DH; Choi IH; Lee DS; Kang MS; Jung KO; Jeon YK; Kim YN; Jung EJ; Lee KB; Sung MS; Kim KT
Int J Gynecol Cancer; 2017 Jun; 27(5):872-878. PubMed ID: 28498255
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of Dickkopf-1 and ß-catenin expression in advanced gastric cancer.
Hong SA; Yoo SH; Lee HH; Sun S; Won HS; Kim O; Ko YH
BMC Cancer; 2018 May; 18(1):506. PubMed ID: 29720122
[TBL] [Abstract][Full Text] [Related]
9. Protective role of V-set and immunoglobulin domain-containing 4 expressed on kupffer cells during immune-mediated liver injury by inducing tolerance of liver T- and natural killer T-cells.
Jung K; Kang M; Park C; Hyun Choi Y; Jeon Y; Park SH; Seo SK; Jin D; Choi I
Hepatology; 2012 Nov; 56(5):1838-48. PubMed ID: 22711680
[TBL] [Abstract][Full Text] [Related]
10. High Yes-associated protein 1 with concomitant negative LATS1/2 expression is associated with poor prognosis of advanced gastric cancer.
Kim E; Ahn B; Oh H; Lee YJ; Lee JH; Lee Y; Kim CH; Chae YS; Kim JY
Pathology; 2019 Apr; 51(3):261-267. PubMed ID: 30819540
[TBL] [Abstract][Full Text] [Related]
11. An antigen processing and presentation signature for prognostic evaluation and immunotherapy selection in advanced gastric cancer.
Wang KW; Wang MD; Li ZX; Hu BS; Wu JJ; Yuan ZD; Wu XL; Yuan QF; Yuan FL
Front Immunol; 2022; 13():992060. PubMed ID: 36311733
[TBL] [Abstract][Full Text] [Related]
12. Optimal proximal resection margin distance for gastrectomy in advanced gastric cancer.
Kim A; Kim BS; Yook JH; Kim BS
World J Gastroenterol; 2020 May; 26(18):2232-2246. PubMed ID: 32476789
[TBL] [Abstract][Full Text] [Related]
13. VSIG4 is highly expressed and correlated with poor prognosis of high-grade glioma patients.
Xu T; Jiang Y; Yan Y; Wang H; Lu C; Xu H; Li W; Fu D; Lu Y; Chen J
Am J Transl Res; 2015; 7(6):1172-80. PubMed ID: 26279760
[TBL] [Abstract][Full Text] [Related]
14. [Clinical study on surgical method and prognosis in diffuse-type advanced gastric cancer].
Yang J; Li L; Zhang G; Zhou H; Yu Z; Jiao Z
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 41(2):151-7. PubMed ID: 26932212
[TBL] [Abstract][Full Text] [Related]
15. A Four-Factor Immunoscore System That Predicts Clinical Outcome for Stage II/III Gastric Cancer.
Wen T; Wang Z; Li Y; Li Z; Che X; Fan Y; Wang S; Qu J; Yang X; Hou K; Zhou W; Xu L; Li C; Wang J; Liu J; Chen L; Zhang J; Qu X; Liu Y
Cancer Immunol Res; 2017 Jul; 5(7):524-534. PubMed ID: 28619967
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of the B7-H4 coregulatory molecule as a novel prognostic marker in gastric cancer.
Arigami T; Uenosono Y; Ishigami S; Hagihara T; Haraguchi N; Natsugoe S
World J Surg; 2011 Sep; 35(9):2051-7. PubMed ID: 21748517
[TBL] [Abstract][Full Text] [Related]
17. Immune checkpoint protein VSIG4 as a biomarker of aging in murine adipose tissue.
Hall BM; Gleiberman AS; Strom E; Krasnov PA; Frescas D; Vujcic S; Leontieva OV; Antoch MP; Kogan V; Koman IE; Zhu Y; Tchkonia T; Kirkland JL; Chernova OB; Gudkov AV
Aging Cell; 2020 Oct; 19(10):e13219. PubMed ID: 32856419
[TBL] [Abstract][Full Text] [Related]
18. CD44V6 in gastric carcinoma: a marker of tumor progression.
Xin Y; Grace A; Gallagher MM; Curran BT; Leader MB; Kay EW
Appl Immunohistochem Mol Morphol; 2001 Jun; 9(2):138-42. PubMed ID: 11396631
[TBL] [Abstract][Full Text] [Related]
19. CD4/CD8 + T cells, DC subsets, Foxp3, and IDO expression are predictive indictors of gastric cancer prognosis.
Li F; Sun Y; Huang J; Xu W; Liu J; Yuan Z
Cancer Med; 2019 Dec; 8(17):7330-7344. PubMed ID: 31631566
[TBL] [Abstract][Full Text] [Related]
20. Crohn's-Like Lymphoid Reaction is Associated with Oncological Prognosis and Nutritional Status in Patients with Pathological Stage II/III Gastric Cancer.
Omura Y; Toiyama Y; Okugawa Y; Yamamoto A; Yin C; Kusunoki K; Kusunoki Y; Shigemori T; Ide S; Kitajima T; Fujikawa H; Yasuda H; Hiro J; Yoshiyama S; Ohi M; Kusunoki M
Ann Surg Oncol; 2020 Jan; 27(1):259-267. PubMed ID: 31414294
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
